The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
2024, April 5 - Seminar of Carine Giovannangeli
26 March 2024
par Isabelle Frapart
2024, March 29 - Seminar of Yu Kimura
26 March 2024
par Isabelle Frapart
2024, March 22 - Seminar of Marie Catherine Sforna
08 March 2024
par Isabelle Frapart